Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Morphine Hydrochloride Sustained-release Tablets

Approval Number

国药准字H10930002

Company西南药业股份有限公司

Registration Date

August 24, 2020

Previous Approval Numbers

国药准字H10930002

Drug Information

Generic Name

盐酸吗啡缓释片

Trade Name

美菲康

Dosage Form

片剂(缓释)

Strength

60mg

Drug Type

化学药品

Registration Date

August 24, 2020

Company Information

Applicant Company

Company Name西南药业股份有限公司

Company Address

重庆市沙坪坝区天星桥21号

Manufacturing Company

Company Name西南药业股份有限公司

Company Address

重庆市沙坪坝区天星桥21号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸吗啡缓释片 - NMPA 批准文号 | MedPath